Overexpression of megsin induces mesangial cell proliferation and excretion of type IV collagen in vitro

Cellular Immunology

Volumn 271, Issue 2, 2011, Pages 413-417

  Xia, Yunfeng ^a   Zhang, Yimin ^b   Shi, Wei ^a   Liu, Shuangxin ^a   Chen, Yuanhan ^a   Liang, Xinling ^a   Ye, Zhiming ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cytokine; Megsin; Mesangial cell; Proliferation; Transfection

Indexed keywords

COLLAGEN TYPE 4; MEGSIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BB; SERINE PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; UPREGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL PROLIFERATION; COLLAGEN TYPE IV; CYTOKINES; MESANGIAL CELLS; PLATELET-DERIVED GROWTH FACTOR; RATS; RNA, MESSENGER; SERPINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 80054019726     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.08.009     Document Type: Article

References (36)

1. Inagi R., Miyata T., Nangaku M., Ueyama H., Takeyama K., Kato S., Kurokawa K. Transcriptional regulation of a mesangium predominant gene, megsin. J. Am. Soc. Nephrol. 2002, 13:2715-2722.
2. Miyata T., Nangaku M., Suzuki D., Inagi R., Uragami K., Sakai H., Okubo K., Kurokawa K. A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. J. Clin. Invest. 1998, 102:828-836.
3. Suzuki D., Miyata T., Nangaku M., Takano H., Saotome N., Toyoda M., Mori Y., Zhang S.Y., Inagi R., Endoh M., Kurokawa K., Sakai H. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases. J. Am. Soc. Nephrol. 1999, 10:2606-2613.
4. Inagi R., Miyata T., Suzuki D., Toyoda M., Wada T., Ueda Y., Izuhara Y., Sakai H., Nangaku M., Kurokawa K. Specific tissue distribution of megsin, a novel serpin, in the glomerulus and its up-regulation in IgA nephropathy. Biochem. Biophys. Res. Commun. 2001, 286:1098-1106.
5. Miyata T., Inagi R., Nangaku M., Imasawa T., Sato M., Izuhara Y., Suzuki D., Yoshino A., Onogi H., Kimura M., Sugiyama S., Kurokawa K. Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. J. Clin. Invest. 2002, 1009:585-593.
6. Kakizaki Y., Kraft N., Atkins R.C. Differential control of mesangial cell proliferation by interferon-gamma. Clin. Exp. Immunol. 1991, 85:157-163.
7. Robertson T.E., Nikolic-Paterson D.J., Hurst L.A., Atkins R.C., Chadban S.J. IL-10 induces mesangial cell proliferation via a PDGF-dependent mechanism. Clin. Exp. Immunol. 2002, 130:241-244.
8. O'Relly M.S., Pirie-Shepherd S., Lane W.S., Folkman J. Antiantiogenic activity of the cleaved conformation of the serpin antithrombin. Science 1999, 285:1926-1928.
9. Lassila M., Jandeleit-Dahm K., Seah K.K., Smith C.M., Calkin A.C., Allen T.J., Cooper M.E. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. J. Am. Soc. Nephrol. 2005, 16:363-373.
10. Nakamura T., Fukui M., Ebihara I., Osada S., Nagaoka I., Tomino Y., Koide H. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993, 42:450-456.
11. Ziyadeh F.N., Hoffman B.B., Han D.C., Iglesias-De La Cruz M.C., Hong S.W., Isono M., Chen S., McGowan T.A., Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc. Natl. Acad. Sci. USA 2000, 97:8015-8020.
12. Schlöndorff D., Banas B. The mesangial cell revisited: no cell is an island. J. Am. Soc. Nephrol. 2009, 20(6):1179-1187.
13. Floege J., Topley N., Hoppe J., Barrett T.B., Resch K. Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells modulation and/or suppression by inflammatory cytokines. Clin. Exp. Immunol. 1991, 14(86):334-341.
14. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999, 79:1283-1316.
15. Iida H., Seifert R., Alpers C.E., Gronwald R.G., Phillips P.E., Pritzl P., Gordon K., Gown A.M., Ross R., Bowen-Pope D.F. Platelet derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc. Natl. Acad. Sci. USA 1991, 88:6560-6564.
16. Terada Y., Yamada T., Nakashima O., Sasaki S., Nonoguchi H., Tomita K., Marumo F. Expression of PDGF and PDGF receptor mRNA in glomeruli in IgA nephropathy. J. Am. Soc. Nephrol. 1997, 8:817-819.
17. Floege J., Eng E., Young B.A., Alpers C.E., Barrett T.B., Bowen-Pope D.F., Johnson R.J. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation, matrix accumulation in rats. J. Clin. Invest. 1993, 92:2952-2962.
18. Isaka Y., Fujiwara Y., Ueda N., Kaneda Y., Kamada T., Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 1993, 92:2597-2601.
19. Gilbert R.E., Kelly D.J., McKay T., Chadban S., Hill P.A., Cooper M.E., Atkins R.C., Nikolic-Paterson D.J. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int. 2001, 15(59):1324-1332.
20. Young B.A., Johnson R.J., Alpers C.E., Eng E., Gordon K., Floege J., Couser W.G., Seidel K. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 1995, 47:935-944.
21. Di Paolo S., Gesualdo L., Ranieri E., Grandaliano G., Schena F.P. High glucose concentration induces the overexpression of transforming growth factor-β through the activation of a platelet-derived growth factor loop in human mesangial cells. Am. J. Pathol. 1996, 149:2095-2106.
22. MacKay K., Striker L.J., Stauffer J.W., Doi T., Agodoa L.Y., Striker G.E. Transforming growth factor-β. Murine glomerular receptors and responses of isolated glomerular cells. J. Clin. Invest. 1989, 83:1160-1167.
23. Massagué J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 1990, 6:597-641.
24. Wolf G. Molecular mechanisms of diabetic mesangial cell hypertrophy: a proliferation of novel factors. J. Am. Soc. Nephrol. 2002, 13:2611-2613.
25. Wolf G., Ziyadeh F.N. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 1999, 56:393-405.
26. Marti H.P., Lee L., Kashgarian M., Lovett D.H. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kD type IV collagenase. Am. J. Pathol. 1994, 144:82-94.
27. Schöklmann H.O., Lang S., Kralewski M., Hartner A., Ludke A., Sterzel R.B. Sixteen distinct structural forms of type I collagen modulate cell cycle regulatory proteins in mesangial cells. Kidney Int. 2000, 58:1108-1120.
28. Woolf A.S., Bosch R.J., Fine L.G. Growth factors in the pathogenesis of renovascular complications of diabetes mellitus. J. Hypertens. 1992, 10:S6-S11.
29. Yang C.W., Striker G.E., Chen W.Y., Kopchick J.J., Striker L.J. Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: studies in mice transgenic for native or mutated growth hormone. Lab. Invest. 1997, 76:467-476.
30. Kalechman Y., Sredni B., Weinstein T., Freidkin I., Tobar A., Albeck M., Gafter U. Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101. J. Am. Soc. Nephrol. 2003, 14:620-630.
31. Kalechman Y., Gafter U., Weinstein T., Chagnac A., Freidkin I., Tobar A., Albeck M., Sredni B. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3. J. Biol. Chem. 2004, 279:24724-24732.
32. Kuo Y.C., Sun C.M., Tsai W.J., Ou J.C., Chen W.P., Lin C.Y. Blocking of cell proliferation, cytokines production and genes expression following administration of Chinese herbs in the human mesangial cells. Life Sci. 1999, 64:2089-2099.
33. Coleman D.L., Ruef C. Interleukin-6: an autocrine regulator of mesangial cell growth. Kidney Int. 1992, 41:604-606.
34. Kashgarian M., Sterzel R.B. The pathobiology of the mesangium. Kidney Int. 1992, 41:524-529.
35. Schindler R., Lonnemann G., Shaldon S., Koch K.M., Dinarello C.A. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int. 1990, 37:85-93.
36. Kuo Y.C., Tsai W.J., Meng H.C., Chen W.P., Yang L.Y., Lin C.Y. Immune responses in human mesangial cells regulated by emodin from Polygonum hypoleucum Ohwi. Life Sci. 2001, 68:1271-1286.